Standard BioTools (LAB) Competitors $1.16 +0.13 (+12.62%) Closing price 04/9/2025 04:00 PM EasternExtended Trading$1.16 0.00 (-0.43%) As of 04/9/2025 04:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LAB vs. TXG, TRNS, CTKB, SENS, ALNT, EYPT, QTRX, QSI, AEHR, and MASSShould you be buying Standard BioTools stock or one of its competitors? The main competitors of Standard BioTools include 10x Genomics (TXG), Transcat (TRNS), Cytek Biosciences (CTKB), Senseonics (SENS), Allient (ALNT), EyePoint Pharmaceuticals (EYPT), Quanterix (QTRX), Quantum-Si (QSI), Aehr Test Systems (AEHR), and 908 Devices (MASS). These companies are all part of the "measuring and control equipment" industry. Standard BioTools vs. 10x Genomics Transcat Cytek Biosciences Senseonics Allient EyePoint Pharmaceuticals Quanterix Quantum-Si Aehr Test Systems 908 Devices 10x Genomics (NASDAQ:TXG) and Standard BioTools (NASDAQ:LAB) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, profitability, risk, community ranking, dividends, media sentiment, institutional ownership and valuation. Which has higher valuation & earnings, TXG or LAB? Standard BioTools has lower revenue, but higher earnings than 10x Genomics. 10x Genomics is trading at a lower price-to-earnings ratio than Standard BioTools, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio10x Genomics$610.79M1.74-$182.63M-$1.52-5.70Standard BioTools$174.43M2.52-$74.66M-$0.55-2.11 Do analysts prefer TXG or LAB? 10x Genomics currently has a consensus price target of $20.21, suggesting a potential upside of 133.15%. Standard BioTools has a consensus price target of $2.50, suggesting a potential upside of 115.52%. Given 10x Genomics' higher probable upside, research analysts plainly believe 10x Genomics is more favorable than Standard BioTools.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score 10x Genomics 1 Sell rating(s) 9 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.35Standard BioTools 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Is TXG or LAB more profitable? 10x Genomics has a net margin of -29.90% compared to Standard BioTools' net margin of -79.92%. 10x Genomics' return on equity of -25.40% beat Standard BioTools' return on equity.Company Net Margins Return on Equity Return on Assets 10x Genomics-29.90% -25.40% -19.69% Standard BioTools -79.92%-27.05%-15.52% Does the media favor TXG or LAB? In the previous week, 10x Genomics had 8 more articles in the media than Standard BioTools. MarketBeat recorded 9 mentions for 10x Genomics and 1 mentions for Standard BioTools. 10x Genomics' average media sentiment score of 0.81 beat Standard BioTools' score of 0.00 indicating that 10x Genomics is being referred to more favorably in the media. Company Overall Sentiment 10x Genomics Positive Standard BioTools Neutral Does the MarketBeat Community prefer TXG or LAB? 10x Genomics received 56 more outperform votes than Standard BioTools when rated by MarketBeat users. However, 83.33% of users gave Standard BioTools an outperform vote while only 50.83% of users gave 10x Genomics an outperform vote. CompanyUnderperformOutperform10x GenomicsOutperform Votes6150.83% Underperform Votes5949.17% Standard BioToolsOutperform Votes583.33% Underperform Votes116.67% Do insiders & institutionals have more ownership in TXG or LAB? 84.7% of 10x Genomics shares are held by institutional investors. Comparatively, 53.7% of Standard BioTools shares are held by institutional investors. 10.0% of 10x Genomics shares are held by company insiders. Comparatively, 53.1% of Standard BioTools shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has more volatility & risk, TXG or LAB? 10x Genomics has a beta of 2.01, suggesting that its share price is 101% more volatile than the S&P 500. Comparatively, Standard BioTools has a beta of 1.54, suggesting that its share price is 54% more volatile than the S&P 500. Summary10x Genomics beats Standard BioTools on 10 of the 18 factors compared between the two stocks. Remove Ads Get Standard BioTools News Delivered to You Automatically Sign up to receive the latest news and ratings for LAB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LAB vs. The Competition Export to ExcelMetricStandard BioToolsAnalytical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$439.62M$4.22B$5.29B$7.69BDividend YieldN/A0.59%5.34%4.26%P/E Ratio-1.6328.2322.0218.06Price / Sales2.524.13349.0490.67Price / CashN/A36.0938.1534.64Price / Book-0.631.626.243.95Net Income-$74.66M-$83.57M$3.19B$247.18M7 Day Performance-1.69%-5.60%-4.11%-4.30%1 Month PerformanceN/A-15.33%-2.47%-7.77%1 Year Performance-60.27%-39.87%3.85%-5.25% Standard BioTools Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LABStandard BioTools2.6965 of 5 stars$1.16+12.6%$2.50+115.5%-60.3%$439.62M$174.43M-1.63620Positive NewsGap DownTXG10x Genomics4.6197 of 5 stars$8.73-4.7%$20.21+131.5%-76.8%$1.07B$610.79M-5.741,240Analyst ForecastNews CoverageGap DownTRNSTranscat2.4967 of 5 stars$74.45+1.5%$111.50+49.8%-31.7%$693.06M$272.20M40.24920Positive NewsCTKBCytek Biosciences1.6138 of 5 stars$4.01+0.3%$6.42+60.0%-45.9%$513.67M$200.45M-50.12500Gap DownSENSSenseonics1.0532 of 5 stars$0.66-2.9%$2.00+204.8%+15.3%$427.68M$22.47M-5.0590Gap DownALNTAllient4.4571 of 5 stars$21.98-2.3%$31.00+41.0%-33.5%$372.52M$529.97M24.981,950Positive NewsGap DownEYPTEyePoint Pharmaceuticals1.7296 of 5 stars$5.42-7.0%$26.63+391.2%-78.8%$372.51M$43.27M-2.71120Positive NewsGap DownQTRXQuanterix2.6929 of 5 stars$6.51-0.8%$18.25+180.3%-74.3%$252.43M$135.44M-6.14460Gap DownQSIQuantum-Si2.7134 of 5 stars$1.20-5.5%$3.48+189.6%-34.9%$219.77M$3.06M-1.88150Gap DownAEHRAehr Test Systems3.3621 of 5 stars$7.29-7.5%$25.00+242.9%-25.6%$216.60M$50.74M9.7290Earnings ReportNews CoverageGap UpMASS908 Devices2.9174 of 5 stars$4.48+10.9%$5.33+19.0%-42.6%$158.28M$59.63M-2.5360Analyst ForecastNews CoverageGap Down Remove Ads Related Companies and Tools Related Companies 10x Genomics Alternatives Transcat Alternatives Cytek Biosciences Alternatives Senseonics Alternatives Allient Alternatives EyePoint Pharmaceuticals Alternatives Quanterix Alternatives Quantum-Si Alternatives Aehr Test Systems Alternatives 908 Devices Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LAB) was last updated on 4/10/2025 by MarketBeat.com Staff From Our PartnersThe Most Bullish Metric For Stocks (NOT Volume…)Before placing a single trade, Tim Sykes always checks one key bullish metric. It’s the same signal that has s...MillPub | SponsoredTrump’s policies mean HUGE income for investorsThanks to a Trump win… Investors have a HUGE opportunity at new income. The floodgates for U.S. oil prod...The Oxford Club | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThis almost killed Elon Musk (chilling details emerge)Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredWhy crypto may be the best way to play this chaotic market …Wall Street is in chaos … Over $6 trillion was wiped … in just two days. But something else was happenin...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Standard BioTools Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Standard BioTools With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LAB Stock Free LAB Stock Alerts